Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Ryde Group (NYSE:RYDE) Launches New Career Pathways Through Upskilling Initiative

Ryde Group Ltd (NYSE:RYDE), Singapore’s homegrown mobility and quick-commerce platform, has completed a major step in expanding career opportunities for its driver-partners. The company announced that the first cohort of drivers has successfully completed the Facilities and Security Management Upskilling Programme, developed in collaboration …

Team Kalkine | 09 December 2025

Structure Therapeutics (NASDAQ:GPCR) Reports Promising Data for Oral GLP-1 Candidate

Structure Therapeutics (NASDAQ:GPCR) saw a major surge in interest after releasing positive topline results from its Phase 2b clinical trial evaluating aleniglipron, its oral GLP-1–based obesity therapy. The data immediately captured market attention, driving the stock sharply higher as confidence grew around the drug’s …

Team Kalkine | 09 December 2025

Carvana (NYSE:CVNA) Marks a Major Milestone With S&P 500 Inclusion

Carvana (NYSE:CVNA) captured attention after being selected for inclusion in theS&P 500, one of the most influentialstock marketindices in the world. The announcement triggered a sharp rise in the company’s share price, as market reacted to its upcoming addition scheduled for Dec. 22.

Team Kalkine | 09 December 2025

Warby Parker (NYSE:WRBY) Joins Google and Samsung in Next-Gen AI Glasses Development

Warby Parker (NYSE:WRBY), known for reshaping the eyewear retail experience, is stepping further into the world of wearable technology. The company gained renewed attention after Google highlighted progress on itsAI-powered glasses project. The collaboration includes Google (NASDAQ:GOOGL), Samsung, and eyewear brand Gentle Monster, forming …

Team Kalkine | 09 December 2025

D-Wave Quantum (NYSE:QBTS) Draws Attention Amid Quantum Tech Momentum

November brought heightened volatility across the technology sector, with concerns surrounding the pace of innovation and the sustainability of valuations. Even though D-Wave Quantum (NYSE:QBTS) is not directly tied to theartificial intelligenceboom, it was still affected by a shift in investor sentiment toward early-stage …

Team Kalkine | 09 December 2025

WVE-007 Trial Success Sends Wave Life Sciences (NASDAQ:WVE) Shares Skyrocketing

Wave Life Sciences (NASDAQ:WVE) made headlines on Monday after announcing interim results from a Phase 1 clinical trial of its investigational weight loss drug, WVE-007. The drug demonstrated a 4.5% reduction in total body fat over three months, compared to no meaningful change in …

Team Kalkine | 09 December 2025

News Corp’s (NASDAQ:NWSA) Stock Ends Lower as Relative Weakness Persists

News Corporation’s (NASDAQ:NWSA) stock closed lower on Monday, slipping 30.50 cents, or 1.2%, to end at$25.73. The decline contrasted with the broader market’s move, as theNASDAQ-100 Index dipped 0.2%, placing NWSA’s relative change at–0.9%for the session.

Team Kalkine | 08 December 2025

Citigroup Revises Rating on Salesforce (NYSE:CRM) After Recent Update

In its latest investor note, Citigroup downgraded Salesforce (NYSE:CRM) from a “strong-buy” rating to “hold,” as reported by Zacks.com. The move reflects evolving assessments of the company’s near-term prospects following its recent earnings release. Citigroup’s change adds to a broader pattern of re-evaluation across …

Aditi Sarkar | 08 December 2025

Wall Street Extends Gains on Rate-Cut Optimism; Commodities, Crypto, and Macro Signals in Focus

Market Movers (Yesterday):Capricor Therapeutics, Inc. surged 371.07%, leading the gainers, followed by iRobot Corporation which jumped 73.85%. Acrivon Therapeutics and several other small-cap biotech names also rallied sharply on short covering and FDA-driven optimism. On the downside, WORK Medical Technology Group Ltd fell 35.94%, …

Team Kalkine | 08 December 2025

Victoria’s Secret (NYSE:VSCO) Posts Narrower Quarterly Loss and Updates Guidance

Victoria’s Secret & Co. (NYSE:VSCO) released its earnings results on Friday. The company reportedEPSof (USD 0.27)for the quarter, which was above the consensus estimate of(USD 0.60). Revenue for the period came in atUSD 1.47 billion, compared with analysts’ expectations ofUSD 1.41 billion. Return on …

Team Kalkine | 08 December 2025